v3.26.1
Condensed Balance Sheets (Unaudited) - USD ($)
Jun. 30, 2026
Dec. 31, 2025
Current Assets    
Cash and cash equivalents $ 3,495,672 $ 3,567,487
Investments 3,135,718 5,943,218
Accounts receivable, net 9,303 5,812
Inventory 1,193,577 1,400,305
Prepaid expenses and other current assets 838,730 681,265
Total Current Assets 8,673,000 11,598,087
Property and equipment, net 152,646 113,929
Right-of-use assets, net 297,836 324,058
Product development costs, net of amortization of $1,052,322 and $833,452, respectively 1,695,567 1,257,447
Software development costs, net of amortization of $1,753,224 and $1,183,765, respectively 2,037,832 2,454,909
Goodwill 3,143,662 3,143,662
Other intangible assets, net of amortization of $7,570,999 and $7,190,101, respectively 1,033,568 1,414,466
Total Assets 17,034,111 20,306,558
Current Liabilities    
Accounts payable 464,172 563,990
Accrued expenses 1,059,156 1,128,424
Deferred revenue 255,598 239,916
Total Current Liabilities 1,778,926 1,932,330
Other long-term liabilities 254,744 282,899
Total Liabilities 2,033,670 2,215,229
Commitments and Contingencies (Note 9)
Series C Redeemable Preferred Stock    
Series C redeemable preferred stock, par value $0.0001 per share: 2,000 shares designated; 1 share issued and outstanding as of June 30, 2026 and December 31, 2025; aggregate liquidation preference of $2,000,000 as of June 30, 2026 and December 31, 2025 1,807,300 1,807,300
Stockholders’ Equity    
Preferred stock, value
Common stock, par value $0.0001 per share: 800,000,000 shares authorized; 899,759 and 906,059 issued and outstanding as of June 30, 2026 and December 31, 2025, respectively 90 91
Additional paid-in capital 132,828,442 132,597,001
Accumulated deficit (119,635,391) (116,632,063)
Total Stockholders’ Equity 13,193,141 16,284,029
Total Liabilities, Series C Redeemable Preferred Stock and Stockholders’ Equity 17,034,111 20,306,558
Series F Preferred Stock    
Stockholders’ Equity    
Preferred stock, value $ 319,000